Table 1.
Phenotypes of BACE1 and BACE2 knockout mice
Putative substrate | References | |
---|---|---|
BACE1 knockout mouse phenotypes | ||
| ||
Astrogenesis increase, neurogenesis decrease | JAG1 | Hu et al (2013)44 |
Axon guidance defects | CHL1 | Rajapaksha et al (2011),34 Cao et al (2012),35 Hitt et al (2012)36 |
Hyperactivity | NRG1 | Dominguez et al (2005),27 Savonenko et al (2008)46 |
Hypomyelination | NRG1 | Willem et al (2006),37 Hu et al (2006),38 Hu et al (2008)39 |
Memory deficits | Unknown | Laird et al (2005),19 Ohno et al (2004),28 Ohno et al (2007),30 Ohno et al (2006),41 Kobayashi et al (2008)40 |
Insulin sensitivity enhanced | Unknown | Dominguez et al (2005),27 Meakin et al (2012),49 Hoffmeister et al (2013)50 |
Muscle spindle reduction | NRG1 | Cheret et al (2013)42 |
Neurochemical deficits | Unknown | Harrison et al (2003)43 |
Neurodegeneration with age | Unknown | Hu et al (2010)45 |
Postnatal lethality, growth retardation | Unknown | Dominguez et al (2005)27 |
Retinal abnormalities | FLT1 | Cai et al (2012)47 |
Schizophrenia endophenotypes | NRG1 | Savonenko et al (2008)46 |
Seizures | SCN2B | Kim et al (2007),51 Kobayashi et al (2008),40 Hu et al (2010),45 Hitt et al (2010)48 |
Spine density reduction | NRG1 | Savonenko et al (2008)46 |
| ||
BACE2 knockout mouse phenotypes | ||
| ||
Normal | .. | Dominguez et al (2005)27 |
Pancreatic β-cell increase | TMEM27 | Esterhazy et al (2009)52 |
Pigmentation abnormalities | PMEL | Rochin et al (2013)53 |
| ||
BACE1/2 knockout mouse phenotypes | ||
| ||
Similar to BACE1 knockout, except postnatal lethality is enhanced | .. | Dominguez et al (2005)27 |